Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A0TI
|
|||
| Former ID |
DIB007117
|
|||
| Drug Name |
TgAAC-09
|
|||
| Synonyms |
AAV-HIV vaccine, Targeted Genetics; AIDS vaccine, Children Hospital/Targeted Genetics; AIDS vaccine, IAVI/Targeted Genetics; HIV vaccine, Targeted Genetics/IAVI/CCRI; RAAV-based vaccine, Targeted Genetics/IAVI; Vaccine (HIV), Childrens Hospital/Targeted Genetics; Vaccine (HIV), Targeted Genetics/IAVI
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 2 | [1] | |
| Company |
Children's Hospital Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00888446) Safety and Immunogenicity Study of tgAAC09, an HIV Vaccine in an Adeno-associated Virus (AAV) Capsid. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.